Theravet S.a. sell Lokrim
Start price
19.02.24
/
20%
€1.04
Target price
19.02.25
-
Performance (%)
-81.54%
End price
17.08.24
€0.19
Summary
This prediction ended on 17.08.24 with a price of €0.19. Lokrim correctly predicted massive losses of -81.54% for Theravet S.a.. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Theravet S.a. | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to Lokrim what are the pros and cons of Theravet S.a. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Little innovation
Comments by Lokrim for this prediction
In the thread Theravet S.a. diskutieren
Sell Theravet S.a.